Becton, Dickinson and Company BDX Medical — D&A

Other segment segments

Similar metrics at other companies

MIRMedical Segment — D&A

$16.2M-1.2%

JNJMedical Devices — D&A

$903M+8.0%

NOVTMedical Solutions — D&A

$9.58M+24.7%

HURNHealthcare — D&A

$1.86M+18.8%

CEEngineered Materials — D&A

$107M-1.8%

CRLManufacturing — D&A

$8.4M-84.6%

Questions, answered.

What is Becton, Dickinson and Company's medical — D&A?

Becton, Dickinson and Company (BDX) reported medical — D&A of $348.25M in Q3 2025.

How has Becton, Dickinson and Company's medical — D&A changed year-over-year?

Becton, Dickinson and Company's medical — D&A increased by 14.6% year-over-year, from $304M to $348.25M.

What is the long-term trend for Becton, Dickinson and Company's medical — D&A?

Over 4 years (2021 to 2025), Becton, Dickinson and Company's medical — D&A has grown at a 6.2% compound annual growth rate (CAGR), from $1.1B to $1.39B.

What does medical — D&A mean?

This metric reflects the systematic allocation of the cost of tangible and intangible assets over their useful lives within the medical segment. It accounts for the wear and tear of manufacturing equipment and the expiration of acquired intangible assets.